Navigation Links
JenaValve Announces First Implantations Of Transapical TAVI System In Canada
Date:8/19/2013

emia, particularly in a patient with coronary artery disease and severe left ventricle dysfunction."

"We use the JenaValve transapical TAVI system on a very regular basis at the University Heart Center Hamburg for patients suffering from aortic valve stenosis who are at too high risk for conventional surgery. We have used the JenaValve in highly stenosed and calcified aortic valves as well as in pure aortic insufficiencies with very promising results," stated Dr. Treede.

Helmut J. Straubinger, CEO of JenaValve Technology, noted that the technology in the JenaValve TAVI system continues to prove its value in a wide variety of patients.

"Our physician partners and everyone at JenaValve continue to be encouraged by the results in challenging cases like these because they demonstrate the potential value of our technology to literally millions of patients around the world. Our second-generation device was designed to overcome the limitations of current first generation devices and we believe these cases again demonstrate that we have made important progress in that effort," Straubinger said. "Our current goal is to expand with our second-generation TAVI device worldwide, to bring a transfemoral and transaortic device to market in 2014, to offer physicians and patients a safe and efficient therapy option."  

About TAVI

Transcatheter aortic valve implantation (TAVI) systems have already yielded nearly $1 billion in revenues worldwide and the market is expected to grow to over $3 billion in 20161. Clinicians are now focused increasingly on TAVI technical and procedural refinements and advancements found in second-generation products such as JenaValve's that address and resolve issues including ease of implantation, the need for post-procedure pacemaker implantation and post-implant paravalvular leakage.

About the JenaValve™ TAVI System

The JenaValve is a true second-generat
'/>"/>

SOURCE JenaValve Technology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. JenaValve Raises $62.5 Million In Venture Funding
2. First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System
3. JenaValve Appoints John F. Migliazza, Chief Operating Officer
4. TetraLogic Pharmaceuticals Announces New Executives
5. Hanger Announces 2013 Year-To-Date Acquisitions Totaling $10 Million Of Annualized Net Revenue
6. International Isotopes Inc. Announces Second Quarter and Six Months 2013 Financial Results
7. Concord Medical Announces Acquisition of Its Shares by CEO and COO from Other Shareholders
8. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
9. Trovagene, Inc. Announces Second Quarter 2013 Earnings
10. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
11. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ST. PAUL, Minn. , Sept. 30, 2014 /PRNewswire/ ... the United States abused prescription pain ... dependence include detoxification or maintenance treatment, which entails the ... and costs of these treatments are important when developing ... studies by pharmacy benefit manager Prime Therapeutics ...
(Date:9/30/2014)... SAN DIEGO , Sept. 30, 2014 /PRNewswire/ ... a three-dimensional biology company focused on delivering breakthrough ... Human Liver Model has been selected as a finalist ... the 2014 Most Innovative New Product Awards, sponsored ... creation of innovative technology and life sciences products ...
(Date:9/30/2014)... -- , A series of Health ... change the way retail pharmaceutical companies are perceived   ... and view pharmacies, Health First Pharmacy is redefining the ... very trendy public demands of customisation and accessibility, the ... various activities for both children and adults starting from ...
Breaking Medicine Technology:Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Health First Pharmacy Redefines 'Pharmacy Retail Experience' 2Health First Pharmacy Redefines 'Pharmacy Retail Experience' 3
... , , NEW YORK , ... Jay Hoffman , PhD, professor and chair of the Department of ... , has shown Sustamine™ L-Alanyl-L-Glutamine, increases performance in endurance exercise and ... in the Journal of the International Society of Sports Nutrition ...
... , SEATTLE , Feb. 11 ... today announced record 2009 sales results. The successful launch of ... in excess of 75% and the company,s first cash flow ... the company,s manufacturing capacity for 2009 and well into 2010. ...
Cached Medicine Technology:Clinical Study Shows Sustamine(TM) L-Alanyl-L-Glutamine Increases Performance in Endurance, Exercise and Activity 2Clinical Study Shows Sustamine(TM) L-Alanyl-L-Glutamine Increases Performance in Endurance, Exercise and Activity 3Clinical Study Shows Sustamine(TM) L-Alanyl-L-Glutamine Increases Performance in Endurance, Exercise and Activity 4Amnis Announces Record 2009 Sales 2
(Date:9/30/2014)... (PRWEB) September 30, 2014 A group of ... to combat an epidemic that, left unchecked, could create a ... are not headed to Africa. John Rogers, the Executive Director ... North Korea to fight a disease most think mankind conquered ... some 80 years ago is on the comeback in several ...
(Date:9/30/2014)... 2014 Bifidobacteria, the primary bacteria found ... diet, and stress, so a high Bifido probiotic can ... Ultimate Flora™ Men’s Complete contains 90 Billion ... Bifidobacteria strains to support a healthy large intestine (colon) ... and 32 billion cultures from 7 Lactobacillus strains to ...
(Date:9/30/2014)... in reducing the stigma associated with seeking help for ... but more improvement is still needed, according to a ... the Defense Department and the Veterans Health Administration to ... not seek needed care for mental health problems. ... treatment as a way to reduce stigma, according to ...
(Date:9/30/2014)... September 30, 2014 Healthcare advocates, patient ... National Association of Health Advocacy Consultants (#NAHAC) fifth annual ... (#NAHAC14) to be held October 30th - Nov. 1st, ... at NAHAC14: Standards and Best Practices for the Field ... a profession, advocates have needed a set of standards ...
(Date:9/30/2014)... Healthpointe is proud to announce that ... and ankle reconstruction surgeries to assist patients with severe ... specializes in the diagnosis and treatment of sports medicine, ... also trained to perform advanced Foot and Ankle Reconstruction ... is also fluent in Spanish. , Reconstructive surgical procedures ...
Breaking Medicine News(10 mins):Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2Health News:ReNew Life Introduces Ultimate Flora™ Men’s Complete Probiotic 90 Billion—Comprehensive Probiotic Support Just for Men 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 2Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 3
... a leader,in the development and marketing of disposable ... announced today that,BSSI has been purchased by Linden ... to Microflex(R), BSSI also owns MicroActive Corporation and,FoodHandler(R), ... leading supplier,of health and safety barrier products to ...
... and special initiatives encourage smokers to say ,I Quit, at The ... ... There,s some,ash-kicking, going on at the BODY WORLDS exhibit. Lung Cancer ... California,s,6-session Ash Kickers Quit Smoking Class and BODY WORLDS, I Quit ...
... Americans Have No Long Term Care Plans, WASHINGTON, ... long term care has on American families, the U.S. ... resolution proclaiming its,support for national Long Term Care Awareness ... one of the nation,s leading providers of,individual long term ...
... raising goal for United Way of ... ... Company,(NYSE: LLY ) chairman and chief executive officer Sidney Taurel ... Lilly,s,commitment to the agency,s 2008 fundraising campaign. For the United Way ...
... researchers find , TUESDAY, Nov. 6 (HealthDay News) -- ... of preclinical cardiovascular disease, U.S researchers report.. , Researchers ... women (who were free of cardiovascular disease at the ... intima media thickness (cIMT), a measure of the ...
... a mother with Alzheimers disease appear to be at higher risk ... according to a new study by NYU School of Medicine researchers. ... in this weeks online edition of the Proceedings of the National ... among cognitively normal people who have a father, a mother, or ...
Cached Medicine News:Health News:Microflex(R) Corporation Acquired by Linden and Edgewater 2Health News:BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking' 2Health News:BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking' 3Health News:Congress Proclaims Support for Long Term Care Awareness Week; Recent Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals 2Health News:Congress Proclaims Support for Long Term Care Awareness Week; Recent Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals 3Health News:Lilly Contributes $10.8 Million to United Way Annual Campaign 2Health News:A maternal link to Alzheimer's disease 2Health News:A maternal link to Alzheimer's disease 3
For the quantitative in vitro determination of Alanine Aminotransferase (ALT) in serum and plasma....
For the quantitative in vitro determination of Alkaline Phosphatase in serum or plasma....
... Tm Bioscience introduces the Tag-It™ Cystic Fibrosis ... cystic fibrosis genotyping. With validated performance criteria, ... will provide superior mutation coverage for carrier ... to diagnosis in newborns. ,The Tag-It™ ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: